1H FY26 Results Announcement
Filed with ASX · · 3 pages · English
Melbourne, Australia & Dallas, United States – February 25, 2026 – Epiminder Limited (ASX: EPI) (“Epiminder” or “the Company”), a pioneer medical device company developing breakthrough epilepsy monitoring technology, is pleased to release its interim financial results for the six months ending on 31 December 2025 (“1H FY26”) for the Company and its subsidiaries. Key Highlights for 1H FY26 Key high
In the deck
Earlier from Epiminder
- 1HFY26 Appendix 4D and Financial Report
- Quarterly Activities/Appendix 4C Cash Flow Report
- First Implant of Minder System in the US
- Finalisation of historical R&D tax claims
Later from Epiminder
- 1H FY26 Results Presentation
- DETECT Study reaches 25th enrolment as momentum builds
- Trading Update
- FY26 Investor Presentation
- FY26 Appendix 4E and Annual Report
Follow Epiminder into a list and get an email when it puts out news.
Follow Epiminder